SLS CIK: 1390478

SELLAS Life Sciences Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.0
FY22:
−23.8
FY23:
−31.4
FY24:
−35.4
FY25:
−28.4
millions USD
FY21:
0
FY22:
−4.50
FY23:
−5.50
FY24:
0
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
12.1
FY22:
24.1
FY23:
22.3
FY24:
46.8
FY25:
86.3
millions USD
FY21:
−13.9
FY22:
−4.23
FY23:
−14.6
FY24:
11.4
FY25:
57.9

All amounts in millions USD Data source:SEC EDGAR